Wednesday, 22 May 2024


AusBiotech expands investment attraction portfolio

12 July 2022 | News

To drive this expanded portfolio, Lisa Renkin has recently joined AusBiotech as Director, Investment

Image credit: shutterstock

Image credit: shutterstock

AusBiotech has announced an expanded investment attraction, commenced in line with a new investment attraction strategy. This strategy was developed in response to feedback from members and industry stakeholders during the development of the Biotechnology Blueprint; A Decadal Strategy for the Australian Biotechnology Industry.

To drive this expanded portfolio, Lisa Renkin has recently joined AusBiotech as Director, Investment. Lisa is well known to many in the sector and has worked collaboratively with AusBiotech and sector stakeholders over many years. Most recently Lisa was the Victorian Deputy Commissioner to China with responsibility for the investment attraction portfolio. 

The investment programme will build on AusBiotech’s successful investment series that has brought together investors and Australian companies seeking capital over the past decade - and will bolster the evidence base and industry-level analysis available by refreshing and creating new resources.   

The work will commence with the development of an environmental, social, and governance (ESG) framework to support reporting for the industry, as it is increasingly important to AusBiotech employees, members and industry stakeholders, including investors, and is strongly aligned with community expectations.

To continue this investment discussion, AusBiotech encourages firms to register for AusBioInvest 2022 on 27 October 2022 in Perth.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account